core technologies
Synovis Orthopedic and Woundcare, Inc. utilizes proprietary crosslinking and sterilization technologies in the processing of its commercialized bioimplants. Conventional methods of crosslinking (e.g. glutaraldehyde) may lead to calcification and encapsulation of biomaterials. Synovis Orthopedic and Woundcare utilizes next generation technologies to maintain the inherent native tissue properties which allow for controlled host remodeling. The sterility of bioimplants is achieved without the involvement of harsh chemicals or gamma irradiation and is assured through stringent USP testing. The optimized advanced biomaterial processing technologies use safe, biocompatible and water soluble components that preserve bioimplant integrity and compatibility.